Company / Revenue
Perspective Therapeutics, Inc. Revenue History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.9M
FY2022
5-year range
$1.6M / $4.8M
FY2018-FY2022
Trend
+22.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 3 consecutive years, from $2M in FY2019 to $3M in FY2022.
Based on SEC 10-K filings.
$3M in FY2022 with a 5-year CAGR of -8.8%.
Improved from $2M to $3M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +23.0%
- 5-Year CAGR
- -8.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Perspective Therapeutics, Inc.'s revenue has grown for 3 consecutive years.
- 5-year CAGR of -8.8%, indicating a declining trend.
- In FY2022, revenue increased 22.1% year-over-year.
- Peak revenue was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $2.9M | +22.1% |
| FY2021 | $2.4M | +3.0% |
| FY2020 | $2.3M | +48.2% |
| FY2019 | $1.6M | -67.2% |
| FY2018 | $4.8M | +3.5% |
| FY2017 | $4.6M | +9.2% |
| FY2016 | $4.2M | -6.8% |
| FY2015 | $4.5M | +0.0% |
| FY2014 | $4.5M | -10.8% |
| FY2013 | $5.1M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026